Brett C.

Brett C. serves as the Senior Director of Finance at ElevateBio, a cell and gene therapy company, since March 2021, contributing to the advancement of innovative medical technologies. Prior experience includes roles as Director of Finance at BioDelivery Sciences International and UPL, and as Director at Arysta LifeScience prior to its acquisition by UPL. Brett's finance career features positions at Alexion Pharmaceuticals, Barclays Capital, and Citi, spanning roles from Associate Director to Analyst, with a focus on corporate finance and structured credit management. Educational qualifications include an M.B.A. in Business and a B.A. in Mathematics, both from the University at Buffalo.